Price increases for generic drugs will be probed by a federal government inspector, according to a letter released on the web site of Sen. Bernie Sanders, a Vermont independent. The Office of the Inspector General for the Department of Health and Human Services will examine the price of the top 200 generic drugs, as ranked by Medicaid reimbursement, from 2005 through 2014. Sanders and Rep. Elijah Cummings, the ranking member of the House Oversight and Government Reform committee, had requested such a probe for both the Medicaid and Medicare programs, after citing data showing price rises. The OIG letter says no such plan for a Medicare review is in the works.
Copyright © 2015 MarketWatch, Inc.